ClinicaliQ Trial Snapshot
- Thrombectomy in PE — Recruiting • Cardiology / Cardiovascular • NCT07650435.
- What is being tested: Catheter-based thrombectomy (mechanical removal of blood clots using a special tube) as a treatment for pulmonary embolism, a potentially life-threatening condition where blood clots lodge in the lungs.
- Patient eligibility overview: The trial includes patients diagnosed with pulmonary embolism who are suitable candidates for the thrombectomy procedure, though specific clinical criteria (such as clot burden, haemodynamic status, or contraindications) would determine individual eligibility.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Pulmonary embolism is a blood clot on the lung, which can cause death or significant reduced quality of life. Sucking the clot out with a special tube (catheter) is a relatively new procedure that can be performed but doesn't have the data required to properly support its use in some patients. We know this procedure works in patients who have no other options and would almost certainly die without intervention. We currently don't know how well this procedure is tolerated, how well it works and what its complications are in…
Eligibility Snapshot
- : 1. Clinical signs and symptoms consistent with acute PE with duration of 14 days or less 2. Patients who present with CT confirmed PE 3. Defined as intermediate or high-risk PE (according to ESC guidelines1) 4. Date of CT imaging from within a two-year period
- Patient is ≥ 18 years of age 6. Informed consent obtained 7. Evidence of cardiac dysfunction (Either biochemical or imaging features of RHS)
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.